healthcare / drug discovery

Research & Innovation - Padua - Italy Research & Innovation : RESEARCH and INNOVATION RESEARCH and DEVELOPMENT BIOPHARMACEUTICAL COMPANY BIOTECHNOLOGY COMPANY RESEARCH LABORATORIES PHARMACEUTICAL INDUSTRY NEUROBIOLOGY and NEUROPHARMACOLOGY FUNCTIONAL GENOMICS FUNCTIONAL PROTEOMICS NEUROSCIENCE NEUROSCIENZE NEUROLOGICAL DISORDERS DRUG DISCOVERY DRUG DEVELOPMENT NEURODEGENERATIVE DISORDERS...

A biotechnology company engaged in the research and development of new, human pharmaceuticals for viral, respiratory diseases and cancer.

Full service marketing communications and advertising firm that offers strategic counsel, creative services, PR and Media Outreach to companies in the life sciences industry.

Mediolanum farmaceutici is an industrial group, based in Italy with subsidiaries in France and USA, dedicated to the discovery, development and commercialisation of a varied portfolio of products, which include drugs to treat hypertension, vascular disorders, inflammatory diseases, allergies, iron deficiencies, infections, myopia and migraine. Mediolanum's present research is focused on ...

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded an extensive portfolio of pharmaceutical compounds including candidates for the trea...

Genelabs Technologies, Inc. is a global biopharmaceutical and diagnostics company focused on gene-regulating drug discovery; infectious diseases including hepatitis; and immunological disorders including lupus.

Products and services from PPD for pharmaceutical, biotechnology and medical device companies, from discovery to preclinical through clinical, drug approval and post-market.

Provides a neutral global forum for the exchange and dissemination of information on the discovery, development, evaluation and utilization of medicines and related health care technologies.

Polymer Laboratories manufactures GPC / SEC & HPLC instrumentation, GPC / SEC & multi detector software, GPC / SEC & HPLC consumables, resins for drug discovery, medicinal / combinatorial chemistry & peptide synthesis and clinical & diagnostic particles for pharma applications. We operate in the USA, UK, Germany, Benelux and France and are supported by a technical worldwide distributor n...

BD products for industrial laboratories and institutions: prefillable syringes and other devices for pharmaceuticals, microbiology products for environmental monitoring, HTS supplies, OEM medical products, OEM precision glass.

Celera's mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medicinal chemistry and biology technology platforms to identify and validate drug targets, a

Biopharmaceutical company studying nuclear receptors, gene deregulation and dedicated to find treatments to cardiovascular diseases, metabolic diseases and inflammatory diseases. Features informations about genomic research and drug dicovery

The RegSource Regulatory page is a comprehensive site to information resources for the pharmaceutical professionals. The site provides links to regulatory and scientific information on the Internet for drug discovery, development and the drug approval process. Links are provided to full text information from the Federal Register (FR) and the information in the FR is focused by therapeuti...

Resource for professionals in the drug development industry- Information on drug discovery and early-stage drug development, discovery technology and more

Cytochroma Inc. - A Canadian Drug Discovery and Development Company

morphochem - Giving wings to drug discovery

BioCryst Pharmaceuticals, Inc. - Small molecule drug discovery...

Natural Product Antibiotic Drug Discovery Biotech Unculturable Microorganisms Unculturables Uncultivable Cambridge, MA

Inte:Ligand - in silico drug discovery and optimization

Argenta Discovery applies integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes, with in-house programmes focusing on respiratory disease.

Leading provider of animal research models, as well as a range of biomedical products and outsourcing services, for use in the discovery, development and testing of new pharmaceuticals

Target-based and chemistry-based technologies enable efficient discovery of new compounds. All current drug candidates discovered using proprietary platform.

Cyano Biotech identifies and characterises natural products by screening cyanobacteria and optimises bioactive compounds regarding harmacological needs employing combinatorial biosynthesis generating novel lead compounds for the pharma industry.

Alcon Laboratories online is the most comprehensive online resource for professionals and consumers. Alcon is a worldwide company committed to the discovery, development and manufacture of ophthalmic products and instrumentation. Alcon researches, develops, manufactures, and markets ophthalmic products, including prescription drugs, contact lens solutions, surgical instruments and access...

Axonyx is a biotechnology company engaged in the discovery, acquisition and development of proprietary pharmaceutical compounds and new technologies useful for the diagnosis and treatment of cognitive disorders including Alzheimer's Disease (AD), a debilitating and fatal disease for which there is no known cure. Axonyx has a portfolio or central nervous system technologies that include f...

Albany Molecular Research, Inc.

Hybridon, Inc. - Technology - Antisense Technology - Antisense...

Cytokinetics translates cell biology into novel pharmaceuticals and technologies. Cytokinetics' drug discovery programs are directed to the field of cytoskeletal pharmacology for the identification of novel classes of therapeutics.

Compugen, a genomics-based drug and diagnostic discovery company, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science, and physics into the disciplines of biology, organic chemistry, and medicine.

Alantos Pharmaceuticals is a biopharmaceutical company which applies a unique and exclusive drug discovery technology - Target Amplified Drug Candidate Evolution (TACE)

Headquartered in Reykjavik, Iceland, deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are p...

DOV Pharmaceutical Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders.

Exelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease.

Incyte: Drug Discovery

You'll find background information about antibody-mediated stroke, new discoveries about the mechanics of the disease, and news of LJP 1082, a potential new treatment for the disease nearing a Phase I/II clinical drug trial.

Momenta Pharmaceuticals Applying scientific breakthroughs in the understanding of sugars to drug discovery, development and commercialization

Orchid - A leader in genetic diversity. Please visit our site for the latest information regarding pharmacogenetics and drug discovery

With leading expertise in fluid handling, tissue culture, and cell screening, BD Biosciences - Discovery Labware provides products and services with applications for drug discovery, ADME/Tox, high throughput-screening, angiogenesis, and tumor invasion.

Æterna Zentaris Inc. is a biopharmaceutical company focused in oncology and endocrine therapy.

SIDR identifies early-stage commercial opportunities in drug research, develops them through proof-of-principal stage, and seeks industrial partners for full development.

With a team of over 150 staff, BioFocus offers fully integrated, multidisciplinary chemistry and biology expertise for pre-clinical drug discovery. These skills, combined with proprietary assay and design technologies provide accelerated partnered programmes for novel lead discovery

Alexion Pharmaceuticals, Inc. is an acute care and specialty biopharmaceutical company engaged in the development and commercialization of innovative drugs that addresses unmet needs in acute cardiovascular and chronic autoimmune disease areas. Our lead program consists of two monoclonal antibody drugs, pexelizumab in for CABG-CPB and AMI indications, and eculizumab for rheumatoid arthri...

Mixture Sciences, Inc., a privately-held biotechnology company, specializes in biomedical research and drug discovery.